Not Yet Recruiting
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Intravenous Anti-CD20/CD30-CAR-T Cell Infusion in Relapsed/Refractory Lymphoma Patients.
NCT06519344
- Conditions
- B Cell Malignancies
- Locations
-
Not specified